182 related articles for article (PubMed ID: 26866350)
1. Elevated interleukin-8 in bile of patients with primary sclerosing cholangitis.
Zweers SJ; Shiryaev A; Komuta M; Vesterhus M; Hov JR; Perugorria MJ; de Waart DR; Chang JC; Tol S; Te Velde AA; de Jonge WJ; Banales JM; Roskams T; Beuers U; Karlsen TH; Jansen PL; Schaap FG
Liver Int; 2016 Sep; 36(9):1370-7. PubMed ID: 26866350
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of TGR5 (GPBAR1) in biliary epithelial cells contributes to the pathogenesis of sclerosing cholangitis.
Reich M; Spomer L; Klindt C; Fuchs K; Stindt J; Deutschmann K; Höhne J; Liaskou E; Hov JR; Karlsen TH; Beuers U; Verheij J; Ferreira-Gonzalez S; Hirschfield G; Forbes SJ; Schramm C; Esposito I; Nierhoff D; Fickert P; Fuchs CD; Trauner M; García-Beccaria M; Gabernet G; Nahnsen S; Mallm JP; Vogel M; Schoonjans K; Lautwein T; Köhrer K; Häussinger D; Luedde T; Heikenwalder M; Keitel V
J Hepatol; 2021 Sep; 75(3):634-646. PubMed ID: 33872692
[TBL] [Abstract][Full Text] [Related]
3. Novel serum and bile protein markers predict primary sclerosing cholangitis disease severity and prognosis.
Vesterhus M; Holm A; Hov JR; Nygård S; Schrumpf E; Melum E; Thorbjørnsen LW; Paulsen V; Lundin K; Dale I; Gilja OH; Zweers SJLB; Vatn M; Schaap FG; Jansen PLM; Ueland T; Røsjø H; Moum B; Ponsioen CY; Boberg KM; Färkkilä M; Karlsen TH; Lund-Johansen F
J Hepatol; 2017 Jun; 66(6):1214-1222. PubMed ID: 28161472
[TBL] [Abstract][Full Text] [Related]
4. Biliary tract instillation of a SMAC mimetic induces TRAIL-dependent acute sclerosing cholangitis-like injury in mice.
Guicciardi ME; Krishnan A; Bronk SF; Hirsova P; Griffith TS; Gores GJ
Cell Death Dis; 2017 Jan; 8(1):e2535. PubMed ID: 28055006
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Biliary Calprotectin as a Biomarker in Primary Sclerosing Cholangitis.
Gauss A; Sauer P; Stiehl A; Rupp C; Krisam J; Leopold Y; Kloeters-Plachky P; Stremmel W; Gotthardt D
Medicine (Baltimore); 2016 Apr; 95(17):e3510. PubMed ID: 27124059
[TBL] [Abstract][Full Text] [Related]
6. Prolonged fibroblast growth factor 19 response in patients with primary sclerosing cholangitis after an oral chenodeoxycholic acid challenge.
Zweers SJ; de Vries EM; Lenicek M; Tolenaars D; de Waart DR; Koelfat KV; Groen AK; Olde Damink SW; Beuers U; Ponsioen C; Jansen PL; Schaap FG
Hepatol Int; 2017 Jan; 11(1):132-140. PubMed ID: 27696157
[TBL] [Abstract][Full Text] [Related]
7. Pathological features of primary sclerosing cholangitis identified by bile proteomic analysis.
Rupp C; Bode KA; Leopold Y; Sauer P; Gotthardt DN
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1380-1389. PubMed ID: 28943450
[TBL] [Abstract][Full Text] [Related]
8. Sclerosing cholangitis with autoimmune pancreatitis versus primary sclerosing cholangitis: comparison on endoscopic retrograde cholangiography, MR cholangiography, CT, and MRI.
Kim JH; Byun JH; Kim SY; Lee SS; Kim HJ; Kim MH; Lee MG
Acta Radiol; 2013 Jul; 54(6):601-7. PubMed ID: 23528564
[TBL] [Abstract][Full Text] [Related]
9. Primary sclerosing cholangitis: evaluation with MR cholangiography-a case-control study.
Fulcher AS; Turner MA; Franklin KJ; Shiffman ML; Sterling RK; Luketic VA; Sanyal AJ
Radiology; 2000 Apr; 215(1):71-80. PubMed ID: 10751470
[TBL] [Abstract][Full Text] [Related]
10. Bile duct bacterial isolates in primary sclerosing cholangitis: a study of explanted livers.
Olsson R; Björnsson E; Bäckman L; Friman S; Höckerstedt K; Kaijser B; Olausson M
J Hepatol; 1998 Mar; 28(3):426-32. PubMed ID: 9551680
[TBL] [Abstract][Full Text] [Related]
11. Increased T helper type 17 response to pathogen stimulation in patients with primary sclerosing cholangitis.
Katt J; Schwinge D; Schoknecht T; Quaas A; Sobottka I; Burandt E; Becker C; Neurath MF; Lohse AW; Herkel J; Schramm C
Hepatology; 2013 Sep; 58(3):1084-93. PubMed ID: 23564624
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence.
Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
Am J Surg Pathol; 2007 Jun; 31(6):907-13. PubMed ID: 17527079
[TBL] [Abstract][Full Text] [Related]
13. Surveillance of primary sclerosing cholangitis with ERC and brush cytology: risk factors for cholangiocarcinoma.
Boyd S; Mustonen H; Tenca A; Jokelainen K; Arola J; Färkkilä MA
Scand J Gastroenterol; 2017 Feb; 52(2):242-249. PubMed ID: 27806633
[TBL] [Abstract][Full Text] [Related]
14. Activation of biliary tree stem cells within peribiliary glands in primary sclerosing cholangitis.
Carpino G; Cardinale V; Renzi A; Hov JR; Berloco PB; Rossi M; Karlsen TH; Alvaro D; Gaudio E
J Hepatol; 2015 Nov; 63(5):1220-8. PubMed ID: 26119688
[TBL] [Abstract][Full Text] [Related]
15. PDX-1/Hes-1 interactions determine cholangiocyte proliferative response to injury in rodents: possible implications for sclerosing cholangitis.
Marzioni M; Saccomanno S; Agostinelli L; Rychlicki C; De Minicis S; Pierantonelli I; Trauner M; Fickert P; Müller T; Shanmukhappa K; Trozzi L; Candelaresi C; Baroni GS; Benedetti A
J Hepatol; 2013 Apr; 58(4):750-6. PubMed ID: 23207146
[TBL] [Abstract][Full Text] [Related]
16. Bile-Derived Organoids From Patients With Primary Sclerosing Cholangitis Recapitulate Their Inflammatory Immune Profile.
Soroka CJ; Assis DN; Alrabadi LS; Roberts S; Cusack L; Jaffe AB; Boyer JL
Hepatology; 2019 Sep; 70(3):871-882. PubMed ID: 30561836
[TBL] [Abstract][Full Text] [Related]
17. Hepcidin is an antibacterial, stress-inducible peptide of the biliary system.
Strnad P; Schwarz P; Rasenack MC; Kucukoglu O; Habib RI; Heuberger D; Ehehalt R; Müller MW; Stiehl A; Adler G; Kulaksiz H
PLoS One; 2011 Jan; 6(1):e16454. PubMed ID: 21283681
[TBL] [Abstract][Full Text] [Related]
18. TLR4, TLR9, and NLRP3 in biliary epithelial cells of primary sclerosing cholangitis: relationship with clinical characteristics.
Matsushita H; Miyake Y; Takaki A; Yasunaka T; Koike K; Ikeda F; Shiraha H; Nouso K; Yamamoto K
J Gastroenterol Hepatol; 2015 Mar; 30(3):600-8. PubMed ID: 25160604
[TBL] [Abstract][Full Text] [Related]
19. In vivo
Mohajeri S; Bezabeh T; Ijare OB; King SB; Thomas MA; Minuk G; Lipschitz J; Kirkpatrick I; Micflikier AB; Summers R; Smith ICP
NMR Biomed; 2019 May; 32(5):e4065. PubMed ID: 30735273
[TBL] [Abstract][Full Text] [Related]
20. Antineutrophil cytoplasmic antibodies in bile are associated with disease activity in primary sclerosing cholangitis.
Lenzen H; Weismüller TJ; Negm AA; Wlecke J; Loges S; Strassburg CP; Manns MP; Lankisch TO
Scand J Gastroenterol; 2013 Oct; 48(10):1205-12. PubMed ID: 23957616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
